July 9 (Reuters) - ContextVision AB COVI.OL :
* Awarded research grant to develop new technology
* Together with its academic partner been awarded a research
grant of 683,000 euros ($758,471.50) for a research program
aimed at developing new imaging technology within prostate
cancer and digital pathology
* Expanded technology platform will position company in
markets with total sales of 1,500 million Swedish crowns
($177.68 million) by 2018
Source text for Eikon: ID:nHUG6CXqPK
Further company coverage: COVI.OL
($1 = 8.4423 Swedish crowns)
($1 = 0.9005 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))